Tuncay Göksel

Tuncay Göksel

Ege University - İzmir / Türkiye
Medical and Health Sciences / Chest Diseases
AD Scientific Index ID: 86953
Ege Üniversitesi
person_outline Tuncay Göksel's MOST POPULAR ARTICLES
1-) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancerGV Scagliotti, P Parikh, J Von Pawel, B Biesma, J Vansteenkiste, ...Journal of clinical oncology 26 (21), 3543-3551, 200840572008
2-) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancerGV Scagliotti, P Parikh, J Von Pawel, B Biesma, J Vansteenkiste, ...Journal of clinical oncology 26 (21), 3543-3551, 200840572008
3-) The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancerP Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ...Journal of Thoracic Oncology 11 (1), 39-51, 201628822016
4-) Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label …TSK Mok, YL Wu, I Kudaba, DM Kowalski, BC Cho, HZ Turna, G Castro, ...The Lancet 393 (10183), 1819-1830, 201931282019
5-) Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label …L Paz-Ares, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ...The Lancet 394 (10212), 1929-1939, 201917222019